Published in Blood on November 01, 1995
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus (1997) 1.52
Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs. A morphological study. Dig Dis Sci (1993) 1.46
Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels: studies under flow conditions. Transfusion (1998) 1.42
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Function of platelet mobile receptors. Thromb Haemost (1992) 1.39
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood (1984) 1.09
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin. J Cardiothorac Vasc Anesth (1999) 1.07
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients. Blood (1991) 1.01
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol (1998) 0.99
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Reconstitution of cytokeratin filaments in vitro: further evidence for the role of nonhelical peptides in filament assembly. J Cell Biol (1984) 0.99
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Hematol (1997) 0.96
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Organization of the actin cytoskeleton of resting and activated platelets in suspension. Am J Pathol (1986) 0.96
Defective platelet adhesion on vessel subendothelium in uremic patients. Blood (1986) 0.95
The critical role of myosin IIA in platelet internal contraction. J Thromb Haemost (2007) 0.94
Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood (1987) 0.94
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum (1998) 0.93
Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion (2005) 0.93
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix. Nephrol Dial Transplant (1995) 0.90
Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. J Thromb Haemost (2011) 0.90
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
Platelet ultrastructural morphometry for diagnosis of partial delta-storage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown origin. A study of 24 cases. Haematologica (2000) 0.89
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology (1996) 0.89
Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions. Transfusion (2000) 0.89
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth (2002) 0.87
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. J Agric Food Chem (2008) 0.87
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Kidney Int (2000) 0.85
Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination. Thromb Res (1985) 0.85
Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion (1999) 0.84
Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability. J Cardiovasc Pharmacol (2001) 0.84
Uremic medium disturbs the hemostatic balance of cultured human endothelial cells. Thromb Haemost (2001) 0.84
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity. Transplant Proc (2006) 0.83
Induction of receptor clustering, patching, and capping on surface-activated platelets. Lab Invest (1990) 0.83
Receptor-ligand complexes are cleared to the open canalicular system of surface-activated platelets. Br J Haematol (1990) 0.83
Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. Haematologica (2000) 0.83
Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine. Thromb Haemost (1986) 0.83
Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium. Thromb Res (1986) 0.83
Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms. J Lab Clin Med (1986) 0.83
Role of actin in platelet function. Eur J Cell Biol (1993) 0.82
Evaluation of ion release, cytotoxicity, and platelet adhesion of electrochemical anodized 316 L stainless steel cardiovascular stents. J Biomed Mater Res B Appl Biomater (2008) 0.82
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. Blood (1986) 0.82
Fibrinogen receptors do not undergo spontaneous redistribution on surface-activated platelets. Arteriosclerosis (1990) 0.82
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul (2001) 0.82
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. Blood (1980) 0.82
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients. Thromb Haemost (1999) 0.82
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. Prostaglandins Med (1981) 0.81
Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets. Am J Pathol (1999) 0.81
The blood platelet open canalicular system: a two-way street. Eur J Cell Biol (1991) 0.81
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. Can J Physiol Pharmacol (1982) 0.81
Induction of GPIb/IX-vWF receptor-ligand translocation on surface-activated platelets. Arterioscler Thromb Vasc Biol (1995) 0.81
Platelet membrane responses to surface and suspension activation. Blood Cells (1990) 0.81
Changes in pericardial calcification due to antiplatelet agents: in vitro studies. Artif Organs (1998) 0.81
Influence of combined thrombin stimulation, surface activation, and receptor occupancy on organization of GPIb/IX receptors on human platelets. Br J Haematol (1994) 0.81
Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease. Am J Hematol (1989) 0.81
Zinc acexamate inhibits gastric acid and pepsinogen secretion in the rat. J Pharm Pharmacol (1990) 0.81
Adherence of platelets under flow conditions results in specific phosphorylation of proteins at tyrosine residues. Cell Adhes Commun (2000) 0.80
Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys (1994) 0.80
Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol (1985) 0.80
Identification of basement membrane components and intermediate filaments in calcifying epithelial odontogenic tumors. J Oral Pathol (1985) 0.80
Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage. Haematologica (1998) 0.80
Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int (1992) 0.80
Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J (1988) 0.80